Hypertrophic osteoarthropathy and related conditions
Hypertrophic osteoarthropathy and related conditions is a research topic within Rheumatology. Science Explorer counts 3.6k research works in it since 1950. 5.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on primary hypertrophic osteoarthropathy and related conditions such as pachydermoperiostosis, digital clubbing, and small intestinal ulceration. It explores the genetic mutations, pathophysiology, clinical features, and treatment options for these conditions, with a particular emphasis on the role of prostaglandin transporter gene SLCO2A1 and vascular endothelial growth factor.
- Hypertrophic Osteoarthropathy
- SLCO2A1 Mutations
- Digital Clubbing
- Prostaglandin Transporter
- Pachydermoperiostosis
- Vascular Endothelial Growth Factor
- Small Intestinal Ulceration
- Pathophysiology
- Clinical Features
- Treatment
- Research works
- 3.6k fractional, since 1950
- In the world top 10%
- 211 per year above
- Top-10% rate
- 5.9% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +17% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Hypertrophic osteoarthropathy and related conditions research?
By volume, the United States and China publish the most (100 and 55 works in 2022–2025).
By volume, 2022–2025
- 1 United States 100 works
- 2 China 55 works
- 3 India 55 works
- 4 Japan 38 works
- 5 United Kingdom 27 works
- 6 Germany 26 works
- 7 Italy 25 works
- 8 Brazil 24 works
- 9 France 21 works
- 10 Spain 19 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Hypertrophic osteoarthropathy and related conditions research?
By volume in 2022–2025, Post Graduate Institute of Medical Education and Research publishes the most Hypertrophic osteoarthropathy and related conditions research, followed by All India Institute of Medical Sciences and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 Post Graduate Institute of Medical Education and ResearchIndia 4 works
- 2 All India Institute of Medical SciencesIndia 3 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 3 works
- 4 Peking Union Medical College HospitalChina 2 works
- 5 Institute of Medical SciencesIndia 2 works
- 6 University of MiamiUnited States 2 works
- 7 Mayo ClinicUnited States 2 works
- 8 Centre Hospitalier Universitaire Mohammed VIMorocco 2 works
- 9 University of PennsylvaniaUnited States 2 works
- 10 Mayo Clinic in ArizonaUnited States 2 works
Where is Hypertrophic osteoarthropathy and related conditions research done?
The largest centres of Hypertrophic osteoarthropathy and related conditions research in 2022–2025 are Beijing (China), Tokyo (Japan), Paris (France) and New Delhi (India).
Is Hypertrophic osteoarthropathy and related conditions research growing?
Output in 2018–2022 was 17% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Hypertrophic osteoarthropathy and related conditions.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.